FOSUN HEALTH Logo

Congenital Heart Disease Treatment

catalogue

Congenital Heart Disease Treatment

Congenital Heart Disease Treatment

Treatment in congenital heart disease does not follow from the diagnosis; it follows from the measurements. The same defect may need nothing at all, a single catheter procedure, or an operation — and the difference between those three answers is the size of the shunt, the state of the chambers and, above all, the pressure in the lung arteries. This page sets out the four routes a patient can be on — surveillance, catheter closure, balloon relief, surgical repair — what each one is suited to, what it cannot do, and why a defect that no longer needs closing is not the same as a defect that has stopped mattering.

Surveillance is a treatment, not a delay

For a large share of patients with a congenital defect, the correct plan for years at a time is to do nothing to the defect and to watch it carefully. That is not a soft option or a decision to postpone: it is a considered choice, made on the same measurements that would justify an intervention, and it carries its own obligations.

Surveillance means something specific. Serial imaging at an interval chosen for the defect — an annual echocardiogram for some patients, one every few years for others; a comparison against the previous study rather than an assessment in isolation; and a defined list of findings that would change the plan, agreed in advance so that neither the patient nor the doctor has to guess. The findings that usually trigger the move from watching to acting are the ones set out on the diagnosis page: a shunt that has grown significant, a chamber that is enlarging, a lung artery pressure that is drifting upward, or a rhythm that has changed. Any of those, plus any clear change in symptoms, reopens the decision.

The obligation that comes with surveillance is attendance. This is the part patients find hardest, because the interval stretches and the patient feels well — and feeling well is exactly what a compensated defect does. The patients who come to harm in this condition are rarely the ones whose defect was small; they are the ones whose defect stopped being small while nobody was measuring.

What to insist on: a written interval and a written list. Ask when the next study is due, what specifically is being watched for, and what result would change the plan. A follow-up described as "come back in a year" without those two answers is harder to keep and easier to lose.

Closing the defect through a catheter

Closure through a catheter is the route most adult patients with a simple defect end up taking, and it is the single biggest change in this field over the past generation. The principle is straightforward: access is gained through a vein — or, for some defects, an artery — in the groin, a sheath is advanced to the heart under X-ray and ultrasound guidance, and a device or a coil is positioned across the defect and deployed so that it sits on both sides of the opening and seals it. Nothing is opened, the heart is not stopped, and most patients are walking the same or the next day.

What makes it possible is anatomy rather than the patient's age or general fitness. A closure device needs enough tissue around the opening to grip: adequate rims on every side, a defect that is not too large for the device sizes available, and enough distance from structures that must not be obstructed, such as a valve or the vessels returning blood from the lungs. Where those conditions are met, catheter closure is used for atrial septal defects, for patent ductus arteriosus and for many ventricular septal defects, and it can be repeated with a second device if a residual leak persists. Where the rims are deficient, the device would be unstable or would interfere with a valve — and that is the situation, not the patient's age, in which surgery is the better answer.

Two practical points are worth knowing before consenting. The mapping is done during the procedure: transoesophageal ultrasound or a small balloon measurement confirms the defect's size and the rims before the device is chosen, so the final decision about which size — or whether a device at all — is made in the room rather than weeks earlier. And a device is a permanent implant: it stays in place for life, needs its position checked at follow-up imaging, and carries the same endocarditis precautions as other implanted cardiac material. Whether that trade-off is acceptable is a reasonable conversation to have explicitly.

When the defect needs an operation

Surgery has not been replaced by catheters; it has been concentrated where it is genuinely the better option. An operation on a congenital defect is performed on a stopped or bypassed heart through the breastbone, under general anaesthesia, with a heart-lung machine taking over the circulation for the time the repair requires. In adult congenital practice it is planned well in advance rather than performed as an emergency, and the plan includes the days in intensive care and a rehabilitation phase afterwards.

Four situations usually point to surgery. The first is anatomy that no device can hold — a defect with poor rims, an opening too large, or one sitting so close to a valve that a device would deform it. The second is a defect that was never closed and now needs to be repaired in an adult, where the surgeon also has to deal with what decades of extra flow have done to the chambers. The third is a defect that also involves a valve: repairing the hole and repairing or replacing the valve in the same operation is often better than two procedures years apart. The fourth is complex anatomy, where the repair is planned by a specialist congenital team and may itself be staged across more than one operation.

One boundary matters here, because patients ask about it constantly. When the valve rather than the hole is the main problem — a bicuspid aortic valve that has become tight or leaky, for instance — the decision-making belongs with valvular heart disease, where valve repair and replacement are discussed in their own terms. The two problems are frequently found in the same heart, and a congenital team and a valve team often work the plan out together; what this page covers is the defect itself.

The four routes, side by side

Once the measurements are in hand, the choice is usually between a small number of options, and it is a comparison rather than a preference. The two procedural families differ in how they reach the defect; the two extremes — surveillance and staged complex repair — differ in what they ask of the patient over time.

Through a catheter

No incision in the chest, a short stay, and a permanent implant left in the heart. Suited to defects with good rims; constraint is the anatomy, not the age.

Through an operation

A chest incision, cardiopulmonary bypass, an intensive care stay and a rehabilitation period. Suited to anatomy a device cannot hold, to combined valve work and to complex repairs.

Route What it suits What it asks of the patient
Surveillance Small shunts, mild valve narrowing, defects that are not enlarging the heart or raising the lung artery pressure Imaging at defined intervals, indefinitely, and reporting any change in exercise tolerance
Catheter closure Atrial septal defect, ventricular septal defect and patent ductus with adequate rims and a suitable size A groin puncture, a short admission, and a permanent implant that must be checked and protected from infection
Balloon relief of a narrowed valve Pulmonary valve stenosis, and selected other narrowings, where opening the valve is the aim A catheter procedure now, with the likelihood that the valve will need review again over the years
Surgical repair Poor rims, defects too large for a device, defects that also involve a valve, and defects repaired late in adulthood An operation with bypass and intensive care, a recovery period, and a scar that itself becomes part of the follow-up
Staged repair of complex anatomy Complex defects, planned by a specialist congenital team, sometimes across more than one operation A lifetime of planned specialist follow-up, with the plan restated at each stage of adult life

Whichever row applies, the same three questions are worth asking before agreeing to anything: what the procedure is expected to change, what it does not change, and what the surveillance looks like afterwards. A plan that answers all three in writing is the one that travels well between hospitals — and it is also the one a patient can follow without needing to remember a conversation.

Why the lung artery pressure decides more than the defect does

There is one measurement in this condition that can move a patient from one end of the treatment range to the other, and it is not the size of the hole. It is the pressure inside the lung arteries, and the reason it carries so much weight is the mechanism of a shunt.

When a shunt sends extra blood to the lungs, the lung vessels receive a volume they were not designed for. For years they accommodate it — relaxing and recruiting more channels — which is why the defect stays quiet. But the accommodation is not free. Persistently raised flow leads to changes in the walls of the small lung arteries, and over time those vessels become less able to relax. The pressure that was only raised during exertion begins to be raised at rest. Once that has happened, the defect behaves differently: the extra flow that was once the problem becomes, in part, the outlet for a lung circulation that has nowhere else to go.

That is why closing a defect is not automatically the right answer, and why the timing of closure is a genuine clinical judgement rather than a formality. When the lung vessels are still reactive, closure removes the extra flow and relieves the load. When the pressure has become fixed and high, closing the hole can remove the escape route and leave the right side of the heart facing the same resistance with less room to manoeuvre — a situation in which some patients are better served by treating the lung circulation rather than the hole. The distinction between those two states can be subtle, which is why it is measured directly at catheterisation rather than inferred from a single echo, and why an assessment by a team that sees this situation regularly is worth the travel.

For a patient, the practical consequence is a question worth asking at every review: is my lung artery pressure stable, and is it still in the range where closure would help me? The answer can change over the years even when nothing in the way the patient feels has changed — and it is the answer that keeps the plan honest.

Life after the repair: what changes, and what does not

A successful repair restores the circulation and usually returns exercise capacity. It does not return the patient to the state of someone who never had a defect, and being clear about that is part of informed care rather than a discouraging note.

What changes: the extra flow through the lungs stops; the load that was enlarging a chamber is removed; the murmur and the most obvious physical findings usually disappear; and, for many patients, breathlessness and fatigue improve over the following months as the heart remodels. What does not change: the heart keeps the history of the defect — a patch, a device or a scar, a chamber that may have been stretched for decades, and conduction tissue that sits close to where the repair was made. So surveillance continues, on a schedule set at the time of repair, and it looks at the rhythm, the valves, the chamber sizes and the lung pressure rather than at the defect, which is no longer there.

  • Rhythm surveillance — because arrhythmia can appear years after a repair, and often at a time when the patient feels otherwise well.
  • Valve and chamber review — to confirm that the geometry has settled and to detect any late enlargement or leak.
  • Lung artery pressure — to confirm that the pressure has fallen and stays down, which is the measure of whether the repair achieved what it was meant to.
  • Infection precautions — for patients with a device, a patch or a prosthetic valve, dental health and a low threshold for investigating persistent fever.
  • Written transfer of information — the operative record, the latest measurements and the current follow-up interval, carried by the patient to any new doctor.

Two questions come up more than any others, and both belong to this stage. Whether a further operation will be needed depends on the specific repair, not on the diagnosis, and it is worth asking directly at the time of the first operation. Whether pregnancy is safe has a similar shape: it depends on the defect, the lung pressure and the pumping function, and it is settled before conception rather than during pregnancy. What protects the heart between visits — activity, vaccination, infection and pregnancy planning — is set out on the prevention page.

Frequently Asked Questions

Will I need another operation later in life?

Sometimes, and the honest answer is that it depends on the repair rather than on the diagnosis. A device closure of a simple defect rarely needs reoperation, although the device itself is checked at follow-up. Some surgical repairs use material that does not grow or does not last indefinitely, and a later procedure may be planned from the outset. A valve that was repaired rather than replaced may need review. The right time to ask is before the first operation, when the surgeon can say what the repair is expected to do over decades.

What is the difference between closing a defect with a device and repairing it with surgery?

The destination is the same — the hole is sealed — and the routes are quite different. A device is delivered through a vein without opening the chest, needs good rims of tissue to hold onto, and leaves a permanent implant inside the heart that is checked at follow-up. Surgery opens the chest, uses bypass, and closes the defect with a patch or sutures; it can handle anatomy a device cannot, and it can address a valve or a malformation at the same time. Neither is an upgrade of the other: the anatomy selects which one applies.

If the defect is repaired, do I still need a cardiologist?

Yes, and this is the single point most often misunderstood by patients who feel completely well after a repair. The heart that was repaired is not the same as a heart that never needed repairing — it carries a scar, a patch or a device, and sometimes a chamber that was stretched before the defect was closed. What follow-up watches for is exactly what a repair does not remove: rhythm changes, valve function and the lung artery pressure. Intervals are often years rather than months, but they are not optional.

Is there an age limit for closing a defect found in adulthood?

Age by itself is not the deciding factor; the state of the heart and the lungs is. Patients well into their later decades have defects closed successfully when the shunt is significant, the lung vessels remain reactive and the anatomy suits a device. What shifts with age is the balance of risk — other conditions, the anaesthetic, and how much of an existing chamber enlargement is likely to reverse. That balance is exactly what the assessment is for, and it is why the answer is individual rather than a cut-off.

Patient Stories

Stories from our congenital heart disease programme, pulled automatically from the patient story library by disease tag.

View all patient stories →

Ask what the plan is meant to change

Send the imaging and the latest measurements, and ask one question in the message: given the shunt and the lung artery pressure, is closure appropriate — and if so, does the anatomy support a catheter approach? A cardiology team will answer in writing, including what the procedure is expected to change, what it will not change, and what surveillance should follow.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*